Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2016)

Biomarin Pharmaceutical (BMRN) has 3 years of Receivables - Other data on file, last reported at $9.0 million in Q3 2012.

• Quarterly Receivables - Other rose 23.81% year-over-year to $9.0 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $9.0 million (up 23.81% YoY) and the FY2011 annual result came in at $6.1 million, down 16.63% from the prior year.
• Receivables - Other declined to $9.0 million in Q3 2012, from $9.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $9.8 million in Q2 2012 to a low of $4.6 million in Q2 2011.
• A 3-year average of $7.3 million and a median of $7.3 million in 2011 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2011 — Receivables - Other declined 16.63% — and 2012, when it surged 111.9%.
• Tracing BMRN's Receivables - Other over 3 years: stood at $7.3 million in 2010, then decreased by 16.63% to $6.1 million in 2011, then surged by 48.01% to $9.0 million in 2012.
• The last three Receivables - Other figures came in at $9.0 million (Q3 2012), $9.8 million (Q2 2012), and $6.8 million (Q1 2012), per Business Quant data.